1380087-89-7 (CPI-0610,2-[(4R)-6-(4-Chlorophenyl)-1-methyl-4H-[1,2]oxazolo[5,4-d][2]benzazepin-4-yl]acetamide)

(4S)-6-(4-氯苯基)-1-甲基-4H-异恶唑并[5,4-d][2]苯并氮杂卓-4-乙酰胺;CPI-0610;

CPI-0610;2-[(4R)-6-(4-Chlorophenyl)-1-methyl-4H-[1,2]oxazolo[5,4-d][2]benzazepin-4-yl]acetamide;4H-Isoxazolo(5,4-d)(2)benzazepine-4-acetamide, 6-(4-chlorophenyl)-1-methyl-, (4S);BDBM50510872;PELABRESIB ANHYDROUS;CPI 0610;1380087-89-7;CPI-232;CPI0610;2-[(4S)-6-(4-chlorophenyl)-1-methyl-4H-[1,2]oxazolo[5,4-d][2]benzazepin-4-yl]acetamide;Pelabresib (CPI-0610);DA-72382;EX-A1612;DTXSID201022544;2-[(7S)-9-(4-CHLOROPHENYL)-3-METHYL-5-OXA-4,8-DIAZATRICYCLO[8.4.0.0(2),?]TETRADECA-1(10),2(6),3,8,11,13-HEXAEN-7-YL]ACETAMIDE;CHEMBL4303404;GLXC-10214;CS-5592;SCHEMBL15926539;compound 10 [PMID: 26815195];AS-73876;BCP10741;NSC784856;2-[(7S)-9-(4-chlorophenyl)-3-methyl-5-oxa-4,8-diazatricyclo[8.4.0.0(2),?]tetradeca-1(14),2(6),3,8,10,12-hexaen-7-yl]acetamide;HY-12863;CPI-0610 anhydrous;NCGC00483135-01;GTPL9120;PELABRESIB [INN];s7853;pelabresib;BC177446;AKOS030526467;2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[e]isoxazolo[5,4-c]azepin-4-yl)acetamide;2-((4S)-6-(4-Chlorophenyl)-1-methyl-4H-isoxazolo(5,4-d)(2)benzazepin-4-yl)acetamide;NSC-784856;UNII-U4017GUQ06;BRD-K19871656-001-01-3;CPI-267232;U4017GUQ06;(S)-2-(6-(4-chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide;62G;Q27076907;

N/A

GCWIQUVXWZWCLE-INIZCTEOSA-N

1S/C20H16ClN3O2/c1-11-18-14-4-2-3-5-15(14)19(12-6-8-13(21)9-7-12)23-16(10-17(22)25)20(18)26-24-11/h2-9,16H,10H2,1H3,(H2,22,25)/t16-/m0/s1

ClC1C=CC(=CC=1)C1C2C=CC=CC=2C2C(C)=NOC=2[C@H](CC(N)=O)N=1